Trial · NCT06037434
Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation
NCT06037434, Unknown, China National Center for Cardiovascular Diseases
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation. Trials, record NCT06037434. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06037434
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation
- NCT number
- NCT06037434
- Status
- Unknown
- Enrollment
- 122 participants, estimated
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Conditions
- Congenital Mitral Insufficiency
- Interventions
- Captopril Tablets, Metoprolol Oral Tablet, Spironolactone Tablets, Torsemide Tablets, Potassium citrate powder
- First posted
- 2023-09-14
- Last updated
- 2023-09-15
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | the recurrence rate of moderate to severe mitral valve regurgitation | after 12 months of treatment | During follow-up visits, echocardiographic examination is conducted to measure the degree of mitral valve regurgitation. If it falls within the moderate to severe range, it is recorded as a recurrence. |
| Secondary | Improvement in symptoms | after 12 months of treatment | Based on patient and caregiver descriptions, if symptoms such as chest discomfort, shortness of breath, and delayed development show improvement following physical activity, it is recorded as an improvement in symptoms. |
| Secondary | Change in left ventricular ejection fraction | after 12 months of treatment | Based on the echocardiogram, measurements are taken for left ventricular ejection fraction. |
| Secondary | Change in left ventricular end-diastolic diameter | after 12 months of treatment | Based on the echocardiogram, measurements are taken for left ventricular end-diastolic diameter. |
| Secondary | NT-proBNP level | after 12 months of treatment | The trend in NT-proBNP levels. |
| Secondary | Incidence rate of drug adverse reactions | after 12 months of treatment | The incidence of abnormalities in complete blood count, electrolytes, liver and kidney function, and cardiac enzymes. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06037434
GET https://conductscience.org/api/trials/v1/NCT06037434/registered